Higher mean cumulative clinic diastolic blood pressure was a strong independent predictor of diabetic retinopathy development or progression, with a 36% increased risk per 1-SD increment (HR 1.36).
Cohort (n=544)
No
What are the independent predictors of development or progression of diabetic retinopathy in high-risk patients with type 2 diabetes?
In high-risk patients with type 2 diabetes, longer diabetes duration, poorer glycemic and lipid control, and higher blood pressures (especially clinic diastolic BP) independently predict the development and progression of diabetic retinopathy.
Hazard Ratio: 1.36 (95% CI 1.14–1.61)
p-value: p=0.001
Abstract Diabetic retinopathy (DR) is a chronic microvascular complication associated a worse prognosis. We aimed to evaluate the predictors of development/progression of DR in a cohort of 544 high-risk patients with type 2 diabetes who had annual ophthalmologic examinations over a median follow-up of 6 years. Ambulatory blood pressure (BP) monitoring and aortic stiffness by carotid-femoral pulse wave velocity were performed. Multivariate Cox survival analysis examined the independent predictors of development or progression of DR. During follow-up, 156 patients either newly-developed or worsened DR. Patients who developed/progressed DR had longer diabetes duration, higher ambulatory and clinic BP levels, higher aortic stiffness, and poorer glycemic control than patients who did not developed/progressed DR. After adjustments for baseline retinopathy prevalence, age and sex, a longer diabetes duration (p < 0.001), higher baseline ambulatory BPs (p = 0.013, for 24-hour diastolic BP), and higher mean cumulative exposure of HbA 1c (p < 0.001), clinic diastolic BP (p < 0.001) and LDL-cholesterol (p = 0.05) during follow-up were the independent predictors of development/progression of DR. BP parameters were only predictors of DR development. In conclusion, a longer diabetes duration, poorer glycemic and lipid control, and higher BPs were the main predictors of development/progression of DR. Mean cumulative clinic diastolic BP was the strongest BP-related predictor.
Cardoso et al. (Mon,) conducted a cohort in Type 2 Diabetes (n=544). Higher mean cumulative clinic diastolic blood pressure vs. Lower mean cumulative clinic diastolic blood pressure was evaluated on Development or progression of diabetic retinopathy (HR 1.36, 95% CI 1.14-1.61, p=0.001). Higher mean cumulative clinic diastolic blood pressure was a strong independent predictor of diabetic retinopathy development or progression, with a 36% increased risk per 1-SD increment (HR 1.36).